March 11, 2021
American CryoStem Corporation (OTC: CRYO) a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has begun processing patient's adipose tissue and culturing mesenchymal stem cells (ATCell™), for use in its FDA approved IND Phase I Clinical Trial.
February 25, 2021
American CryoStem Corporation (OTC: CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida.
January 6, 2021
American CryoStem Corporation (OTC: CRYO), a clinical stage biotechnology Company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) authorized by published code 15 U.S.C. 3710a of US Title 15 Commerce and Trade. (https://www.disa.mil/about/cto/crada-process-overview) The Collaborative work will be conducted at the Biomedical Research Laboratory in Bethesda, Maryland.
December 1, 2020
American CryoStem Corporation Issues Shareholder LetterEATONTOWN, NJ / ACCESSWIRE / December 1, 2020 / American CryoStem Corporation (OTC PINK: CRYO) a clinical stage biotechnology company, global […]
September 23, 2020
American CryoStem Corporation Issues Shareholder LetterEATONTOWN, NJ / ACCESSWIRE / September 23, 2020 / American CryoStem Corporation (OTC PINK:CRYO) is a clinical stage biotechnology company, global licensor, […]
June 29, 2020
American CryoStem Corporation Issues Shareholder LetterThe debt issuance has been executed in accordance with the terms of the Debenture contained in the Company\’s 10-Q through the […]
April 2, 2020
American CryoStem Corporation Issues Shareholder LetterAmerican CryoStem to Develop ATCELL™ Clinical Study for Duchene Muscular Dystrophy with RACEMD April 1, 2020 EATONTOWN, NJ / ACCESSWIRE / April […]
December 5, 2019
American CryoStem Corporation Issues Shareholder LetterEATONTOWN, NJ / ACCESSWIRE / December 5, 2019 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer, and global […]
October 3, 2019
The Company and the Principal Investigator announce the addition of sub-investigators to the clinical trial team with extensive experience assessing and treating athletes and military personnel […]